Trials / Completed
CompletedNCT00158912
VAST - Ventricular Arrhythmia Suppression Trial
Ventricular Arrhythmia Suppression Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 550 (planned)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of VAST is to determine whether the Rate Smoothing feature in Guidant's PRIZM/VITALITY-family ICDs has an effect on the incidence of ventricular tachyarrhythmias.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable Cardioverter Defibrillator |
Timeline
- Start date
- 2003-08-01
- Completion
- 2005-05-01
- First posted
- 2005-09-12
- Last updated
- 2006-11-22
Source: ClinicalTrials.gov record NCT00158912. Inclusion in this directory is not an endorsement.